On July 6, 2026, a clinical trial update was recorded for corticorelin. The trial, titled "Imaging CRF X NOP Interactions in CUD," is registered under identifier NCT05008146. According to the update, the study is currently in Early Phase 1 and its status is listed as recruiting. Corticorelin is an approved compound, and this trial reflects one of its ongoing investigational uses under study. No results have been reported for this trial as of this update. No efficacy or safety outcomes are described in the available record. The update reflects only the trial's current phase and recruitment status as posted. Readers interested in the trial's design, eligibility criteria, or further details can consult the official listing directly. This brief does not characterize the purpose, results, or implications of the imaging study beyond what has been stated. For additional context on corticorelin as a compound, readers may consult the compound overview.</body_markdown>
<parameter name="sources">["https://clinicaltrials.gov/study/NCT05008146"]